We're launching Nucleate to empower the next generation of biotech leaders. Nucleate supports academic founders from the beginning, so they no longer need to graduate prematurely or lose ownership just to give initial life to their ideas. nucleate.xyz

One night last fall, Floris Engelhardt sat down in her Boston apartment and logged onto a Zoom call, armed with a comic and a vague idea about starting a biotech. endpts.com/george-church-…

The program will help scientists in many cities take their work beyond the lab and become startup founders, by giving them access to training, networking, and mentorship opportunities. buff.ly/3umxaxM

NEW: Venture Creation Spotlight, a Nucleate Exclusive Series A groundbreaking series feat. company creation experts from among the most prolific biotech VC firms.

Incredibly excited to announce this Nucleate $1.5M funding award today. Here's what it means for the next generation of biotech founders. 1/5 medium.com/nucleate/nucle…

TODAY is the last day to apply for the free Nucleate Activator program for academic founders. 🎉 The app takes just a few minutes and you don't need your own idea to apply. Please RT to reach more scientists! nucleate.typeform.com/activator-2022

Check out OTC Blog to learn about our Technology Marketing team. otc.duke.edu/news/bringing-… #Marketing #technology

We're grateful for the kind words from Gleb Kuznetsov about Nucleate ('19 cohort). "Nucleate was incredibly valuable for launching @manifoldbio. It's plain silly that the program is entirely free. Anyone interested in starting a company should take advantage of this opportunity."

Announcing the Nucleate 2022 Activator finalists: 79 biotech spinouts from across the country. Learn why we're so excited, and how you can help. 👇

You can help Emilia's Kids Heart Challenge! Donate today! bndfr.com/gk5f9 #Donations #donate #heartdisease #heart #fundraising #help

🚨CALLING ALL TRIANGLE-BASED TECHNOLOGIES🚨 You've told us that you need more time to complete your applications. We have extended the applications to our Activator program. APPLY BY FRIDAY 10/21/22 apply.nucleate.xyz

JOIN US on Tuesday, Oct. 18th from 6-8:30PM at Fullsteam in Durham to learn more about the Nucleate Activator program🎉 APPLY to the 2022 Nucleate RTP Activator program by Oct. 21st📝

Curious how a drug works in the brain? We’re excited to share a preprint: Thousandfold Cell-Specific Pharmacology of Neurotransmission, describing DART.2 (drug acutely restricted by tethering) A🧵(1/8) biorxiv.org/content/10.110…

Come see what DART.2 can do for you. 1st of 6 this morning # PP2. GABA, dopamine, RPE… and a big surprise!! Sasha Burwell is a star graduate student, graduating in the next year. Sasha would be an amazing postdoc recruit!!

DART.2 — 2nd of 6. # V2. Haidun Yan presents bidirectional synapse editing in the retina. A major step towards causal perturbation of the chemical connectome. Amazing collab with @GregDField mad Miranda Scalabrino, PhD.

Awesome turnout!

So honored to feature my PhD work in the Drug Target Review journal and talk about our novel protein evolution platform. Developed Duke University Michael R Tadross lab.